Innospec Schedules Fourth Quarter 2025 Earnings Release and Conference Call
Rhea-AI Summary
Innospec (NASDAQ: IOSP) will release fourth quarter 2025 earnings after market close on Tuesday, February 17, 2026. Management will host a public conference call on Wednesday, February 18, 2026 at 9:00 a.m. ET with Patrick S. Williams, President and CEO, and Ian Cleminson, EVP and CFO.
Investors must register in advance to receive dial-in numbers and a unique PIN to join 5–10 minutes before the call. An audio webcast and slide presentation will be available on the company website, and a replay will be accessible for 30 days.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, IOSP gained 0.66%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
IOSP was up 0.06% while peers like ASH (+3.3%) and CC (+2.58%) showed stronger gains, suggesting a stock-specific, muted reaction to this scheduling update rather than a sector-wide move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 04 | Q3 2025 earnings | Negative | -1.9% | Weaker earnings with sizable special charges and lower EPS vs prior year. |
| Oct 01 | Q3 call scheduled | Neutral | +2.3% | Procedural announcement setting Q3 2025 release date and conference call. |
| Aug 26 | ESG partnership | Positive | +2.1% | Renewed partnership to protect palm oil workers and expand initiatives in 2025. |
| Aug 05 | Q2 2025 earnings | Negative | -3.1% | Mixed segment results with lower net income despite modest revenue growth. |
Result earnings releases have drawn negative reactions, while scheduling calls and ESG partnership news have seen modestly positive price responses, with past moves aligning with the news tone.
Over the last few quarters, Innospec reported Q2 and Q3 2025 earnings with softer profitability and impairments, and shares fell 3.07% and 1.89% respectively. By contrast, an ESG-focused partnership in Aug 2025 and a Q3 2025 earnings-call scheduling release in Oct 2025 produced gains of 2.09% and 2.32%. Today’s Q4 2025 earnings release and call scheduling fits the pattern of procedural communications ahead of full results.
Market Pulse Summary
This announcement set the timetable for Q4 2025 results on February 17, 2026, with a conference call on February 18 at 9:00 a.m. ET. Historically, IOSP’s actual earnings releases, especially Q2 and Q3 2025, have mattered more for price reaction than scheduling notices. Investors may focus on trends in segment margins, cash generation, and any follow-up regulatory filings once full Q4 numbers are reported, using this call as the primary forum for updated detail.
AI-generated analysis. Not financial advice.
ENGLEWOOD, Colo., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release fourth quarter 2025 earnings results on Tuesday, February 17, 2026, after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, February 18, 2026, at 9:00 a.m. ET.
The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal PIN which can be used to join the conference 5-10 minutes prior to the start time.
Online Registration Link: https://register-conf.media-server.com/register/BI401135aee828455e84215dd46099404b
An audio webcast of the conference call will run simultaneously on the company’s website at www.innospec.com. The relevant link as well as the slide presentation for the conference call will be found in the Investor Relations section of the website.
A replay of the webcast can also be accessed from the company’s website and will be available for 30 days following the call.
About Innospec Inc.
Innospec Inc. is an international specialty chemicals company with approximately 2,450 employees in 22 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. The Performance Chemicals business creates innovative technology-based solutions for our customers in the Personal Care, Home Care, Agrochemical, Mining and Industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Oilfield Services provides specialty chemicals to all elements of the oil and gas exploration and production industry.
Forward-Looking Statements
This presentation contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like “expects,” “estimates,” “anticipates,” “may,” “could,” “believes,” “feels,” “plans,” “intends,” “outlook” or similar words or expressions, for example) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future. Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements. Additional information regarding risks, uncertainties and assumptions relating to Innospec and affecting our business operations and prospects are described in Innospec’s Annual Report on Form 10-K for the year ended December 31, 2024, Innospec’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 and other reports filed with the U.S. Securities and Exchange Commission. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading "Risk Factors” in such reports. Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contacts:
Corbin Barnes
Innospec Inc.
+44-151-355-3611
Corbin.Barnes@innospecinc.com